DD's MemCor MBR Selected for Wastewater Treatment Expansion in the UK

DuPont's MemCor MBR Selected for Major UK Wastewater Upgrade

United Utilities has selected DuPont de Nemours, Inc. to provide its MemCor membrane bioreactor (MBR) systems for a significant expansion of wastewater treatment at three sites in North West England.

The MemCor MBR technology will be implemented at the Eccles, Salford, and Wigan facilities following a competitive selection process. This upgrade will enable these plants to comply with more rigorous discharge regulations and produce higher-quality treated water. Notably, the Wigan site, which serves over 437,000 residents, will become the largest MBR facility in the United Kingdom.

Membrane bioreactor systems integrate activated sludge processes with membrane filtration, resulting in enhanced effluent quality and greater operational efficiency. This advanced technology provides consistent performance, adaptability, reduced maintenance, and robust treatment capabilities, strengthening the UK's wastewater infrastructure.

By adopting MBR technology early and at scale within the Asset Management Plan (AMP), United Utilities expects to benefit from cost efficiencies, quicker implementation, improved standardization, and long-term operational advantages. With over three decades of experience and more than 300 installations worldwide, MemCor MBR is recognized for its reliability, effectiveness, and cost savings. DuPont Water Solutions offers a wide range of innovative purification technologies supporting sectors such as power generation, lithium extraction, and green hydrogen production.

Over the past year, DD shares have fallen 37.7%, compared to an 11.7% decline for the broader chemical industry.

Image Source: Zacks Investment Research

DD’s Zacks Rank and Other Noteworthy Stocks

Currently, DD holds a Zacks Rank #1 (Strong Buy).

Other highly rated stocks in the Basic Materials sector include Albemarle Corporation, Compañía de Minas Buenaventura S.A.A., and Balchem Corporation.

Both ALB and BVN are currently rated Zacks Rank #1, while BCPC is ranked #2 (Buy).

• For 2026, the Zacks Consensus Estimate for ALB’s earnings stands at $6.41 per share, reflecting a 911.4% year-over-year increase. ALB has surpassed earnings estimates in each of the last four quarters, with an average surprise of 57.8%. Its shares have surged 139.5% in the past year.
• BVN’s 2026 earnings are projected at $2.16 per share, up 35.85% from the previous year. The company exceeded estimates in three of the last four quarters, averaging a 28.02% surprise. Its stock has climbed 222.6% over the past year.
• BCPC’s 2026 earnings are estimated at $5.53 per share, a 7.4% year-over-year increase. The company beat estimates in two of the last four quarters, and its shares have gained 3.6% in the past year.

Zacks' Top Pick for Potential Growth

Zacks' research team has identified five stocks with the highest potential to double in value in the coming months. Among these, Director of Research Sheraz Mian highlights one standout pick.

This leading choice is a lesser-known satellite communications company. With the space industry expected to reach a trillion-dollar valuation and a rapidly expanding customer base, analysts anticipate a significant revenue surge in 2025. While not every top pick achieves extraordinary gains, this company could outperform previous Zacks selections such as Hims & Hers Health, which rose by 209%.

Further Resources and Reports

Zacks Investment Research